Jesse Cedarbaum

发表

A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease

P. Tariot, D. Arnold, R. Sperling, 2011, Neurology.

Outcome Measures for Disease-Modifying Trials in Parkinson’s Disease: Consensus Paper by the EJS ACT-PD Multi-Arm Multi-Stage Trial Initiative

M. Burnell, P. Piccini, A. Jha, 2023, Journal of Parkinson's disease.